Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „repeated“
Suchtreffer
Begriffe & Kennungen
Arava · 4.5 · Effect on caffeine (CYP1A2 substrate) Repeated doses of A771726 decreased mean Cmax and AUC of caffeine (CYP1A
Eintrag öffnenArava · 4.5 · Effect on caffeine (CYP1A2 substrate) Repeated doses of A771726 decreased mean Cmax and AUC of caffeine (CYP1A
Eintrag öffnenArava · 4.5 · Effect on caffeine (CYP1A2 substrate) Repeated doses of A771726 decreased mean Cmax and AUC of caffeine (CYP1A
Eintrag öffnenArava · 4.5 · Effect on warfarin (CYP2C9 substrate) Repeated doses of A771726 had no effect on the pharmacokinetics of S-war
Eintrag öffnenArava · 4.5 · Effect on warfarin (CYP2C9 substrate) Repeated doses of A771726 had no effect on the pharmacokinetics of S-war
Eintrag öffnenArava · 4.5 · Effect on warfarin (CYP2C9 substrate) Repeated doses of A771726 had no effect on the pharmacokinetics of S-war
Eintrag öffnenAubagio · 4.5 · Effect of teriflunomide on CYP1A2 substrate: caffeine Repeated doses of teriflunomide decreased mean Cmax and
Eintrag öffnenAubagio · 4.5 · Effect of teriflunomide on warfarin Repeated doses of teriflunomide had no effect on the pharmacokinetics of S
Eintrag öffnenAubagio · 4.5 · Potent cytochrome P450 (CYP) and transporter inducers Co-administration of repeated doses (600 mg once daily f
Eintrag öffnenBuvidal · 4.8 · Repeated use of buprenorphine can lead to drug dependence, even at therapeutic doses. The risk of drug depende
Eintrag öffnenBuvidal · 4.8 · Repeated use of buprenorphine can lead to drug dependence, even at therapeutic doses. The risk of drug depende
Eintrag öffnenCabazitaxel Accord · 4.5 · CYP3A inducers Repeated administration of rifampin (600 mg once daily), a strong CYP3A inducer, resulted in an
Eintrag öffnenCabazitaxel Accord · 4.5 · CYP3A inhibitors Repeated administration of ketoconazole (400 mg once daily), a strong CYP3A inhibitor, result
Eintrag öffnenCerdelga · 4.5 · CYP2D6 inhibitors in IMs and EMs After repeated 84 mg twice daily doses of eliglustat in non-PMs, concomitant
Eintrag öffnenCerdelga · 4.5 · CYP3A inhibitors in IMs and EMs After repeated 84 mg twice daily doses of eliglustat in non-PMs, concomitant a
Eintrag öffnenCerdelga · 4.5 · Strong CYP3A inducers After repeated 127 mg twice daily doses of eliglustat in non-PMs, concomitant administra
Eintrag öffnenCholib · 4.5 · Interaction between simvastatin and fenofibrate Effects of repeated administration of fenofibrate on the pharm
Eintrag öffnenCholib · 4.5 · Interaction between simvastatin and fenofibrate Effects of repeated administration of fenofibrate on the pharm
Eintrag öffnenCholib · 4.5 · The repeated administration of simvastatin 40 or 80 mg, the highest dose registered, did not affect the plasma
Eintrag öffnenCholib · 4.5 · The repeated administration of simvastatin 40 or 80 mg, the highest dose registered, did not affect the plasma
Eintrag öffnen